A phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): SWOG study S0329

Por Malhotra, Binu, Moon, James, Kucuk, Omar, Clark, Joseph I, Urba, Susan G, Wolf, Gregory T, Worden, Francis P
Publicado no Head Neck (2014)

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

Por Williamson, Stephen K., Moon, James, Huang, Chao H., Guaglianone, Perry P., LeBlanc, Michael, Wolf, Gregory T., Urba, Susan G.
Publicado em 2010

Docetaxel, cisplatin and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced sq...

Por Adelstein, David J., Moon, James, Hanna, Ehab, Giri, P.G. Shankar, Mills, Glenn M., Wolf, Gregory T., Urba, Susan G.
Publicado em 2010

Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S...

Por Arnold, Susanne M., Moon, James, Williamson, Stephen K., Atkins, James N., Ou, Sai-Hong I., LeBlanc, Michael, Urba, Susan G.
Publicado em 2009

Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: A study based on SWOG protocol S0420

Por MEHTA, SMITA, MOON, JAMES, HASHMI, MEHMOOD, LEBLANC, MICHAEL, HUANG, CHAO HUI, RINEHART, ELIZABETH, WOLF, GREGORY T., URBA, SUSAN G., BANERJEE, SUSHANTA K., WILLIAMSON, STEPHEN
Publicado em 2013

A PHASE II TRIAL OF SURGERY WITH PERIOPERATIVE INGN 201 (Ad5CMV-p53) GENE THERAPY FOLLOWED BY CHEMORADIOTHERAPY FOR ADVANCED, RESECTABLE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,...

Por Yoo, George H., Moon, James, LeBlanc, Michael, Lonardo, Fulvio, Urba, Susan, Kim, Harold, Hanna, Ehab, Tsue, Terry, Valentino, Joseph, Ensley, John, Wolf, Gregory
Publicado em 2009

Circulating CD4-positive lymphocyte levels predict response to induction chemotherapy in patients with advanced laryngeal cancer

Por Dewyer, Nicholas A., Wolf, Gregory T., Light, Emily, Worden, Francis, Urba, Susan, Eisbruch, Avraham, Bradford, Carol R., Chepeha, Douglas B., Prince, Mark E., Moyer, Jeffrey, Taylor, Jeremy
Publicado no Head Neck (2013)

Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer

Por Schneider, Bryan J., Lee, Julia Shin-Jung, Hayman, James A., Chang, Andrew C., Orringer, Mark B., Pickens, Allan, Pan, Charlie C., Merajver, Sofia D., Urba, Susan G.
Publicado no Invest New Drugs (2012)

Classification of TP53 Mutations and HPV Predict Survival in Advanced Larynx Cancer

Por Scheel, Adam, Bellile, Emily, McHugh, Jonathan B., Walline, Heather M., Prince, Mark E., Urba, Susan, Wolf, Gregory T., Eisbruch, Avraham, Worden, Francis, Carey, Thomas E., Bradford, Carol
Publicado no Laryngoscope (2016)

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

Por Samuels, Stuart E., Stenmark, Matthew H., Lee, Jae Y., McHugh, Jonathan B., Hayman, James A., Orringer, Mark B., Urba, Susan G., Sun, Libin, Xie, Congying, Kong, Feng-Ming, Cuneo, Kyle C.
Publicado no Adv Radiat Oncol (2017)

Chemotherapy alone for organ preservation in advanced laryngeal cancer

Por Divi, Vasu, Worden, Francis P., Prince, Mark E., Eisbruch, Avraham, Lee, Julia S., Bradford, Carol R., Chepeha, Douglas B., Teknos, Theodoros N., Hogikyan, Norman D., Moyer, Jeffrey S., Tsien, Christina I., Urba, Susan G., Wolf, Gregory T.
Publicado em 2010

INFILTRATING LYMPHOCYTES AND HUMAN PAPILLOMAVIRUS-16 ASSOCIATED OROPHARYNX CANCER

Por Wansom, Derrick, Light, Emily, Thomas, Dafydd, Worden, Francis, Prince, Mark, Urba, Susan, Chepeha, Douglas, Kumar, Bhavna, Cordell, Kitrina, Eisbruch, Avraham, Taylor, Jeremy, Moyer, Jeffrey, Bradford, Carol, D’Silva, Nisha, Carey, Thomas, McHugh, Jonathan, Wolf, Gregory
Publicado em 2012

Correlation of Cellular Immunity with Human Papillomavirus 16 Status and Outcome in Patients with Advanced Oropharyngeal Cancer

Por Wansom, Derrick, Light, Emily, Worden, Frank, Prince, Mark, Urba, Susan, Chepeha, Douglas B, Cordell, Kitrina, Eisbruch, Avraham, Taylor, Jeremy, D’Silva, Nisha, Moyer, Jeffrey, Bradford, Carol R, Kurnit, David, Kumar, Bhavna, Carey, Thomas E, Wolf, Gregory T
Publicado em 2010

Survival Rates Using Individualized Bioselection Treatment Methods in Patients with Advanced Laryngeal Cancer : The University of Michigan Experience

Por Wolf, Gregory T., Bellile, Emily, Eisbruch, Avraham, Urba, Susan, Bradford, Carol R., Peterson, Lisa, Prince, Mark E., Teknos, Theodoros N., Chepeha, Douglas B., Hogikyan, Norman D., McLean, Scott A., Moyer, Jeffery, Taylor, Jeremy MG, Worden, Francis P.
Publicado no JAMA Otolaryngol Head Neck Surg (2017)

Induction chemotherapy followed by chemoradiation for organ preservation compared to surgery with selective chemoradiation in patients with advanced oral cavity carcinoma

Por Chinn, Steven B., Spector, Matthew E., Bellile, Emily L., Rozek, Laura S., Lin, Tasha, Teknos, Theodoros N., Prince, Mark E., Bradford, Carol R., Urba, Susan G., Carey, Thomas E., Eisbruch, Avraham, Wolf, Gregory T., Worden, Francis P., Chepeha, Douglas B.
Publicado em 2014

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Por Sohal, Davendra P.S., Mangu, Pamela B., Khorana, Alok A., Shah, Manish A., Philip, Philip A., O’Reilly, Eileen M., Uronis, Hope E., Ramanathan, Ramesh K., Crane, Christopher H., Engebretson, Anitra, Ruggiero, Joseph T., Copur, Mehmet S., Lau, Michelle, Urba, Susan, Laheru, Daniel
Publicado no J Clin Oncol (2016)

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer

Por LaBonte, Melissa J., Yang, Dongyun, Zhang, Wu, Wilson, Peter M., Nagarwala, Yasir M., Koch, Kevin M., Briner, Colleen, Kaneko, Tomomi, Rha, Sun-Young, Gladkov, Oleg, Urba, Susan G., Sakaeva, Dina, Pishvaian, Michael J., Hsieh, Ruey-Kuen, Lee, Wei-Ping, Lenz, Heinz-Josef
Publicado no Mol Cancer Ther (2016)

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update

Por Sohal, Davendra P.S., Kennedy, Erin B., Khorana, Alok, Copur, Mehmet S., Crane, Christopher H., Garrido-Laguna, Ignacio, Krishnamurthi, Smitha, Moravek, Cassadie, O’Reilly, Eileen M., Philip, Philip A., Ramanathan, Ramesh K., Ruggiero, Joseph T., Shah, Manish A., Urba, Susan, Uronis, Hope E., Lau, Michelle W., Laheru, Daniel
Publicado no J Clin Oncol (2018)

Biomarkers in Advanced Larynx Cancer

Por Bradford, Carol R., Kumar, Bhavna, Bellile, Emily, Lee, Julia, Taylor, Jeremy, D’Silva, Nisha, Cordell, Kitrina, Kleer, Celina, Kupfer, Robbi, Kumar, Pawan, Urba, Susan, Worden, Francis, Eisbruch, Avraham, Wolf, Gregory T., Teknos, Theodoros N., Prince, Mark E.P., Chepeha, Douglas B., Hogikyan, Norman D., Moyer, Jeffrey S., Carey, Thomas E.
Publicado em 2013

Response to Therapy and Outcome in Oropharyngeal Cancer are Associated with Biomarkers Including HPV, EGFR, Gender and Smoking

Por Kumar, Bhavna, Cordell, Kitrina G., Lee, Julia S., Prince, Mark E., Tran, Huong H., Wolf, Gregory T., Urba, Susan G., Worden, Francis P., Chepeha, Douglas B., Teknos, Theodoros N., Eisbruch, Avraham, Tsien, Christina I., Taylor, Jeremy M.G., D'Silva, Nisha J., Yang, Kun, Kurnit, David M., Bradford, Carol R., Carey, Thomas E.
Publicado em 2007